Trump signs new, expanded executive order to lower U.S. drug prices

WASHINGTON (Reuters) - President Donald Trump signed a new executive order on Sunday aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July action.

Reuters September 14, 2020 06:10:10 IST
Trump signs new, expanded executive order to lower U.S. drug prices

Trump signs new expanded executive order to lower US drug prices

WASHINGTON (Reuters) - President Donald Trump signed a new executive order on Sunday aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July action.

"My Most Favored Nation order will ensure that our Country gets the same low price Big Pharma gives to other countries. The days of global freeriding at America’s expense are over," Trump said in a Twitter post.

The latest step, coming less than two months before the Nov. 3 presidential election, would replace a July 24 Trump executive order.

It extends the mandate to prescription drugs available at a pharmacy, which are covered under Medicare Part D. The July version focused on drugs typically administered in doctors' offices and health clinics, covered by Medicare Part B.

Specifically, it would pay a price for a drug that matches the lowest price paid among wealthy foreign governments. Medicare, the government healthcare program for seniors, is currently prohibited from negotiating prices it pays to drugmakers.

It also requires issuing new federal rules, a complex process that might not be done by Election Day. Furthermore, determining prices paid by other countries could be challenging as negotiations between governments and drugmakers often are kept confidential.

The industry's largest trade group - the Pharmaceutical Research and Manufacturers of America, or PhRMA - denounced Trump's move as "a reckless attack on the very companies working around the clock to beat COVID-19 ."

PhRMA President and Chief Executive Stephen Ubl called the policy "unworkable" and an "overreach," and said it would give foreign governments a say in how the United States provides access to treatments.

Larry Levitt, health economist at the Kaiser Family Foundation research organization, wrote on Twitter that Trump's executive order "does not by itself do anything. It has to be followed up by regulations, which will take time."

The Biotechnology Innovation Organization said the move would reduce industry investment. "We will use every tool available – including legal action if necessary – to fight this risky foreign price control scheme," Dr. Michelle McMurry-Heath, president and CEO of the group, said in a statement.

The Republican president signed an executive order in July to require Medicare to tie the prices it pays for drugs to those paid by other countries. Its implementation, however, was delayed as the administration sought to work out a solution with the industry.

Three other executive orders were signed in July, which were designed to reduce drug costs for consumers in a bid to highlight Trump's commitment to cutting prescription prices before the November election.

The orders ranged from relaxing drug importation rules to cutting Medicare payments to drugmakers.

(Reporting by Doina Chiacu, Susan Cornwell and Richard Cowan in Washington; Michael Erman in Maplewood, New Jersey; Editing by Nick Zieminski and Peter Cooney)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Greek police clash with protesters in rally against mandatory vaccinations
World

Greek police clash with protesters in rally against mandatory vaccinations

ATHENS (Reuters) - Greek police used teargas and water cannon to disperse people who had gathered in central Athens on Saturday to protest against mandatory COVID-19 vaccinations. More than 4,000 people rallied outside the Greek parliament for a third time this month to oppose mandatory inoculations for some workers, such as healthcare and nursing staff.

Two Turkish soldiers killed in attack in northern Syria
World

Two Turkish soldiers killed in attack in northern Syria

ISTANBUL (Reuters) - Two Turkish soldiers were killed and two were wounded in an attack on their armoured vehicle in northern Syria, and Turkish forces immediately launched retaliatory fire, Turkey's defence ministry said on Saturday. "Our punitive fire against terrorist positions is continuing," the statement on Twitter on said. It did not specify where the attack occurred, but media reports said it was in the al-Bab area.

Brazilians take to streets again to demand Bolsonaro's impeachment
World

Brazilians take to streets again to demand Bolsonaro's impeachment

By Marcelo Rochabrun SAO PAULO (Reuters) - Protesters took to the streets in several Brazilian cities on Saturday to demand the impeachment of far-right President Jair Bolsonaro, whose popularity has fallen in recent weeks amid corruption scandals against the backdrop of the pandemic. This week, news broke that Brazil's defense ministry told congressional leadership that next year's elections would not take place without amending the country's electronic voting system to include a paper trail of each vote. Bolsonaro has suggested several times without evidence that the current system is prone to fraud, allegations that Brazil's government has denied